GO:1902634 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process: Lipid Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902634 describes the biological process that breaks down 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate (PIP2), a critical membrane phospholipid involved in signal transduction and cytoskeletal regulation [1, 7].
• PIP2 catabolism is mediated by phospholipase C (PLC) and phosphoinositide phosphatases, generating second messengers such as IP3 and DAG, or recycling PIP2 into phosphatidylinositol [1, 4].
• This process is essential for calcium signaling, vesicle trafficking, ion channel regulation, and actin cytoskeleton dynamics [3, 6, 8].
• Dysregulation of PIP2 catabolism is implicated in cancer, neurodegeneration, and immune disorders [1, 2, 5].
• Key enzymes include PLCB1, PLCG1, PLCG2, PTEN, INPP5B, OCRL, and SYNJ1, which are frequent targets in CRISPR knockout and point-mutation studies [1, 4].
• Studying GO:1902634 requires integrated approaches such as live-cell imaging of PIP2 reporters, lipidomics, and CRISPR-based gene editing to dissect enzyme-specific contributions [7, 8].
Description
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate (PIP2) is a minor but functionally pivotal phospholipid in eukaryotic membranes. The catabolic process defined by GO:1902634 encompasses the enzymatic reactions that degrade PIP2, thereby terminating its signaling functions and recycling its components [1, 7]. This process is not merely a housekeeping degradation pathway; it is a tightly regulated signaling node that controls diverse cellular outcomes including calcium release, protein kinase C activation, and membrane remodeling [1, 3]. Researchers study GO:1902634 to understand how cells decode and terminate lipid signals, and how perturbations in this pathway contribute to diseases such as cancer and neurodegeneration [1, 2, 5]. The availability of CRISPR tools now enables precise interrogation of the enzymes and regulators that execute PIP2 catabolism, making this GO term a focal point for functional genomics [4, 8].
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process At A Glance
| GO ID | GO:1902634 |
|---|---|
| GO term | 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process |
| Ontology | biological_process |
| Synonym | 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate breakdown; 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolism; 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate degradation |
| Major function | Degradation of PIP2 to terminate signaling and recycle lipid precursors |
| Key enzymes | Phospholipase C (PLCB1, PLCG1, PLCG2), phosphoinositide phosphatases (PTEN, INPP5B, OCRL, SYNJ1) |
| Subcellular location | Plasma membrane, endomembranes, and membrane contact sites |
| Related processes | Phosphoinositide signaling, calcium homeostasis, actin cytoskeleton regulation |
What Is GO:1902634?
GO:1902634, 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process, is defined by QuickGO as the chemical reactions and pathways resulting in the breakdown of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate. In simpler terms, it covers all enzymatic steps that convert PIP2 into other molecules, such as inositol 1,4,5-trisphosphate (IP3), diacylglycerol (DAG), or phosphatidylinositol, thereby reducing the cellular pool of PIP2 [1, 4].
Why Is 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process Important in Cell Biology?
PIP2 catabolism is a central mechanism for switching off lipid-mediated signals and for generating second messengers that propagate cellular responses [1, 3]. Because PIP2 itself regulates ion channels, transporters, and actin-binding proteins, its degradation directly impacts membrane excitability, vesicle trafficking, and cell shape [6, 8]. Consequently, enzymes that catabolize PIP2 are frequently mutated or dysregulated in human diseases, including cancer, immune deficiencies, and neurological disorders [1, 2, 5]. Understanding GO:1902634 therefore provides mechanistic insight into both normal physiology and disease pathogenesis, and it offers a rich set of targets for therapeutic intervention and CRISPR-based functional studies [4, 7].
• Controls termination of PIP2-dependent signaling at the plasma membrane [1, 7].
• Generates IP3 and DAG, which mediate calcium release and protein kinase C activation [1, 3].
• Regulates ion channels such as KCNQ5 through PIP2 availability.
• Modulates actin cytoskeleton dynamics via PIP2-binding proteins like capping proteins.
• Influences vesicle trafficking and neurotransmission through lipid turnover.
• Dysregulation is linked to cancer, neurodegeneration, and immune disorders [1, 2, 5].
• Provides targets for CRISPR knockout and point-mutation studies of PLC and phosphatase genes.
• Serves as a model for understanding how cells decode and terminate lipid second messengers.
What Happens During 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process?
Phospholipase C-mediated hydrolysis
In simple terms: Enzymes cut PIP2 into two messenger molecules.
The primary route of PIP2 catabolism is hydrolysis by phospholipase C (PLC) enzymes, which cleave PIP2 into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). This reaction is a key step in phosphoinositide signaling and is activated downstream of many receptors, including G protein-coupled receptors and receptor tyrosine kinases [1, 3]. The resulting IP3 triggers calcium release from intracellular stores, while DAG remains in the membrane to activate protein kinase C [1, 3].
Dephosphorylation by phosphoinositide phosphatases
In simple terms: Other enzymes remove phosphate groups from PIP2 to recycle it.
PIP2 can also be degraded by phosphoinositide phosphatases, such as PTEN, INPP5B, OCRL, and SYNJ1, which remove specific phosphates to generate phosphatidylinositol 4-phosphate or phosphatidylinositol [4, 7]. These reactions are essential for maintaining the steady-state levels of PIP2 and for recycling the inositol lipid backbone. Dysregulation of these phosphatases alters PIP2 availability and downstream signaling [1, 4].
Regulation by membrane environment and protein partners
In simple terms: The membrane context and binding partners control how fast PIP2 is broken down.
PIP2 catabolism is influenced by the local lipid composition, membrane curvature, and the presence of scaffolding proteins that recruit or inhibit catabolic enzymes. For example, phosphatidic acid and other lipids can modulate enzyme activity and membrane targeting. Additionally, PIP2 itself regulates ion channels and cytoskeletal proteins, so its degradation is tightly coupled to changes in membrane excitability and actin dynamics [6, 8].
Coupling to downstream cellular responses
In simple terms: Breaking down PIP2 sends signals that change cell behavior.
The products of PIP2 catabolism act as second messengers that propagate signals to diverse effectors. IP3 mobilizes calcium, which controls secretion, contraction, and gene expression. DAG activates protein kinase C and other targets, influencing proliferation and differentiation. In parallel, the loss of PIP2 from the membrane alters the activity of ion channels such as KCNQ5 and actin-regulatory proteins, thereby linking lipid catabolism to electrical and structural plasticity [6, 8].
Recycling and resynthesis
In simple terms: The breakdown products can be reused to rebuild PIP2.
After dephosphorylation, the resulting phosphatidylinositol can be re-phosphorylated by phosphatidylinositol phosphate kinases to regenerate PIP2, completing a cycle that allows cells to rapidly reset lipid signaling. This recycling is critical for sustained signaling and for maintaining membrane identity. The balance between catabolism and resynthesis determines the size and dynamics of the PIP2 pool [1, 4].
Key Genes Involved in GO:1902634 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process
The following genes encode enzymes and regulators that directly participate in or control the catabolism of PIP2, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PLCB1 | Hydrolyzes PIP2 to IP3 and DAG | Key enzyme in calcium signaling; knockout models show neurological defects [1, 3] |
| PLCG1 | Hydrolyzes PIP2 downstream of receptor tyrosine kinases | Oncogenic roles in cancer; target for point-mutation studies |
| PLCG2 | Hydrolyzes PIP2 in immune cells | Mutations linked to immune disorders; CRISPR models available [1, 2] |
| PTEN | Dephosphorylates PIP3 to PIP2, indirectly affecting PIP2 catabolism | Tumor suppressor; frequent knockout in cancer research [1, 4] |
| INPP5B | Phosphatidylinositol 5-phosphatase that degrades PIP2 | Regulates endosomal trafficking; knockout models exist |
| OCRL | Phosphatidylinositol 5-phosphatase | Mutations cause Lowe syndrome; studied via CRISPR |
| SYNJ1 | Phosphatidylinositol 5-phosphatase | Implicated in neurodegeneration; knockout models available |
| KCNQ5 | Ion channel regulated by PIP2 | PIP2 catabolism affects channel activity; point-mutation studies |
| CAPZA1 | Actin capping protein regulated by PIP2 | Links PIP2 catabolism to cytoskeleton; knockout studies |
| CAPZB | Actin capping protein regulated by PIP2 | Cytoskeletal dynamics; CRISPR models |
| DGKQ | Diacylglycerol kinase that consumes DAG from PIP2 hydrolysis | Regulates DAG signaling; knockout models |
| PIK3CA | Generates PIP3, indirectly influencing PIP2 pools | Oncogenic; point-mutation models |
| PIK3CB | Generates PIP3, indirectly influencing PIP2 pools | Cancer and metabolism; knockout models |
| INPP4A | Inositol polyphosphate 4-phosphatase | Affects PIP2 recycling; knockout studies |
| INPP4B | Inositol polyphosphate 4-phosphatase | Tumor suppressor; CRISPR models |
| STING1 | Regulated by phosphoinositides including PIP2 | Immune signaling; knockout and point-mutation models |
| PLCD1 | Hydrolyzes PIP2 in specific tissues | Role in differentiation; knockout models |
| PLCE1 | Hydrolyzes PIP2 in kidney and other tissues | Implicated in nephropathy; CRISPR models |
How Is 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process Regulated?
PIP2 catabolism is regulated at multiple levels. Receptor activation recruits and activates phospholipase C isoforms, often via G proteins or tyrosine phosphorylation. Phosphatases such as PTEN and INPP5B are controlled by lipid binding, phosphorylation, and protein-protein interactions. The lipid environment, including phosphatidic acid, can modulate enzyme activity and membrane recruitment. Additionally, PIP2 itself feedback-regulates ion channels and cytoskeletal proteins, so its degradation is coupled to changes in membrane tension and cytoskeletal organization [6, 8]. This multilayered regulation ensures that PIP2 catabolism is tuned to cellular needs and can be rapidly adjusted during signaling.
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTEN | Cancer (tumor suppressor loss) | Knockout in cancer cell lines; point mutations for phosphatase-dead variants |
| PLCG1 | Cancer (oncogenic signaling) | Point mutation of catalytic domain; overexpression |
| PLCG2 | Immune disorders | Knockout in immune cells; knock-in of patient mutations |
| SYNJ1 | Neurodegeneration | Knockout in neurons; point mutations linked to disease |
| OCRL | Lowe syndrome | Knockout in renal cells; knock-in of patient mutations |
Cancer
Alterations in PIP2 catabolism are common in cancer. PTEN loss leads to accumulation of PIP3 and dysregulated PIP2 signaling, promoting tumor growth [1, 4]. Activating mutations in PIK3CA and overexpression of PLCG1 similarly drive oncogenic signaling. Targeting these enzymes with CRISPR knockout or point-mutation models helps dissect their contributions to tumorigenesis [1, 4].
Neurodegeneration
SYNJ1 mutations have been linked to neurodegenerative disorders, and PIP2 catabolism is important for synaptic vesicle recycling and neurotransmission [4, 5]. Disruption of PIP2 turnover affects neuronal function and survival, making this pathway a focus for neurodegeneration research [4, 5].
Immune disorders
PLCG2 and STING1 are regulated by phosphoinositides, and mutations in these genes cause immune dysregulation [1, 2]. PIP2 catabolism influences immune cell activation and cytokine production, providing a link between lipid signaling and immunity.
Developmental and metabolic disorders
OCRL mutations cause Lowe syndrome, a developmental disorder characterized by cataracts, intellectual disability, and kidney dysfunction. INPP5B and other phosphatases also affect endosomal trafficking and metabolism, highlighting the broad physiological impact of PIP2 catabolism.
From 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PLCB1 affect PIP2 catabolism and calcium signaling? | CRISPR knockout in HEK293 or neuronal cells |
| How do point mutations in PLCG1 alter enzyme activity? | CRISPR point mutation knock-in in cancer cell lines |
| What is the effect of PTEN phosphatase-dead mutation on PIP2 levels? | CRISPR point mutation knock-in in cancer cells |
| Can overexpression of INPP5B rescue PIP2 accumulation? | CRISPR overexpression in knockout background |
| How does SYNJ1 mutation affect synaptic vesicle recycling? | Knock-in of disease mutation in iPSC-derived neurons |
| What is the role of KCNQ5 PIP2-binding site in channel regulation? | CRISPR point mutation in KCNQ5 gene |
How to Study the 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell PIP2 imaging | Real-time PIP2 levels | Monitor catabolism after stimulation |
| Lipidomics (LC-MS) | PIP2 and metabolite abundance | Validate enzyme knockout effects |
| Calcium imaging | IP3-mediated calcium release | Assess PLC activity |
| CRISPR knockout screens | Gene essentiality and pathway regulators | Identify novel regulators of PIP2 catabolism |
| Phosphoinositide pulldown | Protein-lipid interactions | Study effector recruitment |
| Western blot | Protein expression and phosphorylation | Confirm knockout or knock-in |
| RNA-seq | Transcriptional changes | Analyze downstream gene expression |
| Proteomics | Protein abundance and interactions | Map signaling networks |
Live-cell imaging of PIP2 reporters
Genetically encoded PIP2 reporters, such as PLCδ-PH-GFP, allow real-time visualization of PIP2 dynamics at the plasma membrane. This method is used to monitor catabolism after receptor activation or enzyme manipulation.
Lipidomics and mass spectrometry
Mass spectrometry-based lipidomics quantifies PIP2 and its metabolites, providing direct biochemical evidence of catabolic flux. It is applied to validate CRISPR knockout or point-mutation effects on lipid levels.
Calcium imaging
Calcium-sensitive dyes or genetically encoded indicators measure IP3-mediated calcium release following PIP2 hydrolysis. This is a standard readout for PLC activity and PIP2 catabolism.
CRISPR screening and functional genomics
Pooled CRISPR knockout screens can identify genes that regulate PIP2 catabolism and downstream phenotypes [1, 4]. Bioinformatics analysis of screen data reveals pathways and networks controlling this process.
How CRISPR Can Be Used to Study GO:1902634 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process
Knockout
CRISPR knockout of genes such as PLCB1, PLCG1, PTEN, or SYNJ1 eliminates enzyme function, allowing researchers to measure the impact on PIP2 catabolism and downstream signaling [1, 4]. Knockout cell lines are valuable for identifying compensatory pathways and for drug sensitivity studies.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to disable catalytic activity while preserving protein interactions [4, 8]. For example, phosphatase-dead PTEN mutants or PIP2-binding-deficient KCNQ5 mutants help dissect specific functions [4, 8].
Knock-in
Knock-in of tagged or reporter alleles enables tracking of enzyme localization and dynamics in live cells. Disease-relevant mutations can also be knocked in to create isogenic models for mechanistic studies.
Overexpression
CRISPR-mediated overexpression of phosphatases or PLC isoforms can elevate catabolic flux and reduce PIP2 levels, providing gain-of-function models [1, 4]. These models are useful for testing rescue experiments and for screening for modifiers.
How EDITGENE Supports 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process Research
Researchers studying 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process-related genes often need to determine whether a candidate gene is causally involved in lipid signaling, and CRISPR-based models provide the most direct way to establish causality. EDITGENE offers a comprehensive suite of gene editing services tailored to this pathway.
Contact EDITGENE today to design your custom CRISPR model for 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process research.
Frequently Asked Questions About 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process
What is 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process?
It is the biological process defined by GO:1902634 that breaks down PIP2 into second messengers or recycled lipids [1, 4].
What genes are involved in PIP2 catabolism?
Key genes include PLCB1, PLCG1, PLCG2, PTEN, INPP5B, OCRL, and SYNJ1, among others [1, 4].
How is PIP2 catabolism regulated?
It is regulated by receptor signaling, lipid environment, and protein-protein interactions that control enzyme recruitment and activity [1, 5, 7].
Why is PIP2 catabolism important for cells?
It terminates PIP2 signaling and generates IP3 and DAG, which control calcium release, PKC activation, and cytoskeletal dynamics [1, 3, 6].
What diseases are linked to PIP2 catabolism?
Cancer, neurodegeneration, immune disorders, and Lowe syndrome have been associated with dysregulated PIP2 catabolism [1, 2, 4].
How can CRISPR be used to study PIP2 catabolism?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of enzymes and regulators in this pathway [1, 4, 8].
What methods measure PIP2 catabolism?
Live-cell imaging with PIP2 reporters, lipidomics, calcium imaging, and CRISPR screens are commonly used [3, 4, 7].
Which enzyme hydrolyzes PIP2 into IP3 and DAG?
Phospholipase C enzymes, including PLCB1, PLCG1, and PLCG2, catalyze this hydrolysis.
What is the role of PTEN in PIP2 catabolism?
PTEN dephosphorylates PIP3 to PIP2 and indirectly influences PIP2 pools and downstream signaling [1, 4].
How does PIP2 catabolism affect ion channels?
PIP2 itself regulates channels like KCNQ5, so its degradation alters channel activity and membrane excitability.
Conclusion
GO:1902634, the catabolic process of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate, is a fundamental lipid signaling pathway that controls calcium, PKC, ion channels, and the cytoskeleton [1, 3, 6, 8]. Its dysregulation contributes to cancer, neurodegeneration, and immune disorders, making it a rich area for therapeutic targeting [1, 2, 4]. CRISPR-based models are indispensable for dissecting the specific roles of PLCs and phosphatases in this process [1, 4]. EDITGENE provides end-to-end services to create these models and to analyze the resulting data, empowering researchers to advance the field.
References
- 1. Cantley LC. 2002. The phosphoinositide 3-kinase pathway.. Science 296(5573):1655-7 PMID: 12040186
- 2. Li J et al.. 2026. Regulation of STING activation by phosphoinositide and cholesterol.. Nature 652(8109):499-507 PMID: 41639452
- 3. Taylor CW. 2002. Controlling calcium entry.. Cell 111(6):767-9 PMID: 12526803
- 4. Giudici ML et al.. 2004. Phosphatidylinositol phosphate kinases.. J Endocrinol Invest 27(6 Suppl):137-42 PMID: 15481814
- 5. Raben DM et al.. 2017. Phosphatidic acid and neurotransmission.. Adv Biol Regul 63:15-21 PMID: 27671966
- 6. Weeds A et al.. 1993. F-actin capping proteins.. Curr Opin Cell Biol 5(1):63-9 PMID: 8383512
- 7. Hurley JH et al.. 2001. Subcellular targeting by membrane lipids.. Curr Opin Cell Biol 13(2):146-52 PMID: 11248547
- 8. Yang Z et al.. 2025. Phosphatidylinositol 4,5-bisphosphate activation mechanism of human KCNQ5.. Proc Natl Acad Sci U S A 122(14):e2416738122 PMID: 40172963
